Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?
- PMID: 20191573
- PMCID: PMC2924189
- DOI: 10.1002/acr.20167
Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?
Comment on
-
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.Arthritis Care Res (Hoboken). 2010 May;62(5):704-11. doi: 10.1002/acr.20209. Arthritis Care Res (Hoboken). 2010. PMID: 20461789
Similar articles
-
Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy.Arthritis Care Res (Hoboken). 2010 May;62(5):704-11. doi: 10.1002/acr.20209. Arthritis Care Res (Hoboken). 2010. PMID: 20461789
-
[Clinical case of the month. Hepatitis B reactivation in an Ag HBs negative patient].Rev Med Liege. 2007 Mar;62(3):135-8. Rev Med Liege. 2007. PMID: 17511378 French.
-
Reactivation of Resolved Hepatitis B virus Infection before the Relapse of Lymphoma : Immunosuppressive effect of the Lymphoproliferative disorders?Acta Gastroenterol Belg. 2016 Mar;79(1):63-4. Acta Gastroenterol Belg. 2016. PMID: 26852769
-
Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.World J Gastroenterol. 2013 Mar 7;19(9):1342-8. doi: 10.3748/wjg.v19.i9.1342. World J Gastroenterol. 2013. PMID: 23538480 Free PMC article. Review.
-
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.Crit Rev Oncol Hematol. 2013 Jul;87(1):12-27. doi: 10.1016/j.critrevonc.2012.12.004. Epub 2013 Jan 11. Crit Rev Oncol Hematol. 2013. PMID: 23313021 Review.
Cited by
-
Hepatitis B Serology in Patients with Rheumatic Diseases.Open Rheumatol J. 2016 Aug 31;10:39-48. doi: 10.2174/1874312901610010039. eCollection 2016. Open Rheumatol J. 2016. PMID: 27708728 Free PMC article.
-
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Ann Rheum Dis. 2011 Jun;70(6):909-20. doi: 10.1136/ard.2010.144998. Epub 2011 Mar 6. Ann Rheum Dis. 2011. PMID: 21378402 Free PMC article.
-
Leveraging the electronic health record to improve quality and safety in rheumatology.Rheumatol Int. 2017 Oct;37(10):1603-1610. doi: 10.1007/s00296-017-3804-4. Epub 2017 Aug 29. Rheumatol Int. 2017. PMID: 28852846 Free PMC article. Review.
-
Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications.Jt Comm J Qual Patient Saf. 2019 May;45(5):348-357. doi: 10.1016/j.jcjq.2018.12.003. Epub 2019 Jan 25. Jt Comm J Qual Patient Saf. 2019. PMID: 30686706 Free PMC article.
-
Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.Mod Rheumatol. 2011 Dec;21(6):621-7. doi: 10.1007/s10165-011-0458-z. Epub 2011 Apr 29. Mod Rheumatol. 2011. PMID: 21528424 Free PMC article.
References
-
- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis. 2004;11(2):97–107. - PubMed
-
- Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ. 2009;58(3):1–27. - PubMed
-
- Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1–20. - PubMed
-
- Narvaez J, Rodriguez-Moreno J, Martinez-Aguila MD, Clavaguera MT. Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy. The Journal of rheumatology. 1998;25(10):2037–8. - PubMed
-
- Ito S, Nakazono K, Murasawa A, et al. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis and rheumatism. 2001;44(2):339–42. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical